0:00 2026年元旦假期后的首个交易日（1月2日），港股迎来开门红，恒生指数涨超700点，涨幅达2.76%， 恒生科技指数涨4%。 兴业证券指出，2026年港股市场将延续牛市格局，行情节奏如"火炬登山"般震荡上行，投资主线聚 焦"成长乘势聚力+价值重构红利"。不过，市场也需警惕短期波动风险。 （声明：文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。） "港股GPU第一股"壁仞科技上市首日一度涨近120%，收盘涨超75%，总市值达822亿港元。 科网股午后持续走强，百度集团涨超9%，新东方涨超7%，网易涨超6%，阿里巴巴、腾讯控股涨超 4%，快手、京东涨超3%。 资料显示，2025年全年港股通累计净流入港股1.406万亿港元，同比增长74%，内资成为市场稳定运行 的"压舱石"。 ...

2026年首个交易日（1月2日），港股迎来开门红，恒生指数涨超700点，涨幅达2.76%，恒生科技指数 涨4%。 | 名称 | 现价 | 涨跌 | 涨跌幅 ▼ | | --- | --- | --- | --- | | 万得(港股)中国科技龙头指数 | 9390.99 c | 369.54 | 4.10% | | 恒生科技 | 5736.44 c | 220.46 | 4.00% | | 万得(港股)中国科技指数 | 2626.07 c | 83.72 | 3.29% | | 恒生中国企业指数 | 9168.99 c | 255.31 | 2.86% | | 恒生中国(香港上市)100 | 7517.71 с | 206.21 | 2.82% | | 恒生指数 | 26338.47 c | 707.93 | 2.76% | "港股GPU第一股"壁仞科技上市首日一度涨近120%，收盘涨超75%，总市值达826亿港元。半导体板块 涨幅居前，华虹半导体涨超9%，中芯国际涨超5%。 | 名称 | 现价 | 涨跌 | 涨跌幅 ▼ | | --- | --- | --- | --- | | 百度集团-SW | 143.8 ...

记者丨刘雪莹 高升 编辑丨倪新平 2026年首个交易日（1月2日），港股迎来开门红，恒生指数涨超700点，涨幅达2.76%，恒生科技指数 涨4%。 | 名称 | 现价 | 涨跌 | 涨跌幅 ▼ | | --- | --- | --- | --- | | 万得(港股)中国科技龙头指数 | 9390.99 c | 369.54 | 4.10% | | 恒生科技 | 5736.44 c | 220.46 | 4.00% | | 万得(港股)中国科技指数 | 2626.07 c | 83.72 | 3.29% | | 恒生中国企业指数 | 9168.99 c | 255.31 | 2.86% | | 恒生中国(香港上市)100 | 7517.71 c | 206.21 | 2.82% | | 恒生指数 | 26338.47 c | 707.93 | 2.76% | "港股GPU第一股"壁仞科技上市首日一度涨近120%，收盘涨超75%，总市值达826亿港元。半导体板块 涨幅居前，华虹半导体涨超9%，中芯国际涨超5%。 科网股午后持续走强，百度集团涨超9%，新东方涨超7%，网易涨超6%，阿里巴巴、腾讯控股涨超 4%，快手 ...

记者丨刘雪莹 高升 2026年首个交易日（1月2日），港股迎来开门红，恒生指数涨超700点，涨幅达2.76%，恒生 科技指数涨4%。 | 名称 | 现价 | 涨跌 | 涨跌幅 ▼ | | --- | --- | --- | --- | | 万得(港股)中国科技龙头指数 | 9390.99 с | 369.54 | 4.10% | | 恒生科技 | 5736.44 c | 220.46 | 4.00% | | 万得(港股)中国科技指数 | 2626.07 с | 83.72 | 3.29% | | 恒生中国企业指数 | 9168.99 c | 255.31 | 2.86% | | 恒生中国(香港上市)100 | 7517.71 с | 206.21 | 2.82% | | 恒生指数 | 26338.47 с | 707.93 | 2.76% | "港股GPU第一股"壁仞科技上市首日一度涨近120% ，收盘涨超75%，总市值达826亿港元。 半导体板块涨幅居前，华虹半导体涨超9%，中芯国际涨超5%。 科网股午后持续走强 ，百度集团涨超9%，新东方涨超7%，网易涨超6%，阿里巴巴、腾讯控 股涨超4%，快手、京东涨超 ...

恒生指数高开0.9%，恒生科技指数涨1.02%。盘面上，黄金等有色金属股高开，招金矿业涨约2%，紫金 矿业涨超3%；锂电池板块活跃，宁德时代涨近3%，赣锋锂业涨超2%。 本文转载自"腾讯自选股"，智通财经编辑：徐文强。 关于港股后市 光大证券认为，与往年牛市相比，当前指数仍然有相当大的上涨空间，但是在国家对于"慢牛"的政策指 引之下，牛市持续的时间或许要比涨幅更加重要。不过短期来看，市场可能缺乏强力催化，叠加年末部 分投资者在行为上可能趋于稳健，股市短期或以震荡蓄势为主。 国信证券表示，港股短期调整为2026年市场上涨打开空间。从资金面上看，11月南向资金净流入港股市 场超1100亿元人民币。今年南向资金在港股下跌时依然逆向加仓，这既体现了内地资金的充裕流动性， 也彰显了其低位布局港股的强烈意愿。该机构预测，港股2026年有望在30000-32000点之间运行。 中信证券认为，2026年港股将迎来第二轮估值修复，第二轮估值修复的核心逻辑，在于内外因素的共振 发力。对于2026年港股配置，需紧扣"业绩确定性+估值弹性"主线，在科技、医药、资源品与必选消费 四大赛道中寻找机会。 ...

盘面上，大型科技股走势分化，阿里巴巴跌1.5%，腾讯控股涨0.17%，京东集团跌0.44%，小米集团涨 0.91%，美团涨0.8%，快手跌0.15%，哔哩哔哩跌0.1%；芯片股走低，中兴通讯跌13.08%，华虹半导体 跌4.8%，上海复旦跌2.55%；医药板块下跌，银诺医药跌超7%，歌礼制药跌超5%。风电股涨幅居前， 金风科技涨超5%，东方电气涨超4%；光伏太阳能股普跌，协鑫科技跌超7%；京东工业今日上市首日平 收。其他股票方面，红星美凯龙跌14.4%，汇量科技涨14.8%，思摩尔国际涨8.5%，蓝思科技、宁德时 代涨2%。 企业新闻 舜宇光学科技(02382.HK)：11月手机镜头出货量约1.19亿件，环比减少2.3%，同比增长7.5%；车载镜头 出货量为1263.4万件，环比增长3.4%，同比增加69.4%。手机摄像模组出货量为4149万件，环比减少 7.8%，同比增长10.9%。 丘钛科技(01478.HK)：11月手机摄像头模组销量为3805.3万件，环比减少13.6%，同比减少5.6%。摄像 头模组销售数量合计4175.5万件，环比减少11.9%，同比增长0.4%。指纹识别模组销售数量合计1779. ...

文 | 银行螺丝钉 （转载请注明出处） 有朋友问，近期市场有所波动，还在牛市吗？ A股 港股 的牛市有哪些特点？是慢牛还是快牛？ 面对这样的市场，我们该如何应对？之后市场还会继续上涨吗？ 针对大家的这些疑问，螺丝钉也通过直播课，进行了讲解。 长按识别下面二维码，添加 @课程小助手 微信，回复「 1202 」即可观看直播回放。 （提示：回复后可以耐心等待几秒哦～） A股目前仍处在牛市 每个投资者对牛市的定义不同。 国际上，一般从熊市底部上涨超20%，认为进入到技术性牛市。 反之，从顶部回调超20%，认为进入到技术性熊市。 那为什么会有这样一个约定俗成的牛市定义呢？其实这跟大盘指数的波动率有关系。 全球主流股票市场的宽基指数，比如沪深300、标普500，它们的年波动率一般就在10%~20%上下。 一旦某些年份，这些指数的涨跌大幅超过20%，投资者就会认为市场进入了技术性牛市或熊市。 但是从体感上，投资者一般把涨到指数点数较高位置的时候，叫做牛市。 比如2007年、2015年，当时大盘涨到了五六千点。 从2024年9月的最低点，到2025年10月最高点，中证全指上涨61.93%，进入到技术性牛市。 2025年11月 ...

Core Viewpoint - The Hong Kong stock market, particularly the innovative drug sector, is experiencing a significant rally, with institutions optimistic about the market's future trajectory despite previous adjustments, indicating a continuation of the long-term bull market [1][6][7]. Summary by Sections Innovative Drug Sector Performance - On December 4, the innovative drug sector in Hong Kong saw substantial gains, with companies like Gilead Sciences rising over 11%, and WuXi Biologics and WuXi AppTec increasing by over 7% [2]. - Other notable performers included companies like InnoCare Pharma and BeiGene, which also experienced significant increases [2]. Strategic Developments - WuXi Biologics announced a strategic cooperation memorandum with the Qatar Free Zone Authority, aiming to establish an integrated CRDMO center in the Middle East [4]. - According to research from CMB International, the overall orders and performance in the CXO sector are expected to recover significantly by 2025, driven by improved financing conditions and an increase in overseas demand [4]. Market Outlook and Analyst Recommendations - Analysts from Ping An Securities highlighted the optimization of the medical insurance fund structure and policies encouraging high-quality innovative drug development, suggesting a focus on companies with leading technological platforms in the CXO field [5]. - Nomura reiterated a "buy" rating for WuXi AppTec, raising its target price from HKD 130.63 to HKD 132.8, citing the company's strong R&D capabilities and significant project backlog [5]. - As of September 2025, WuXi Biologics has secured 3,430 projects, three times the number from 2021, with total order backlog reaching CNY 59.88 billion, and new orders increasing by 32% year-on-year [5]. Broader Market Trends - The Hong Kong stock market indices, including the Hang Seng Index and Hang Seng Tech Index, showed positive movements, with gains of 0.68% and 1.45% respectively on December 4 [6]. - Analysts predict a shift in investment logic from traditional valuation recovery to a revaluation based on new productivity and high-quality development, with expectations for moderate expansion in valuation and earnings in 2026 [6]. - The market is anticipated to benefit from internal catalysts and external economic policies, with a forecast for a second round of valuation recovery and further performance improvement in 2026 [7].

Group 1 - The event "10th Zhitong Finance Capital Market Annual Conference and Listed Company Awards Ceremony" was held in Shenzhen, focusing on the theme "Winning the Hong Kong Stock Surge: Bullish Start for the East 2026" [1] - The Hong Kong stock market has become a global capital focus, with the Hang Seng Index and Hang Seng Tech Index rising over 30% in 2025, and net inflows from southbound funds exceeding 1.2 trillion HKD [1][2] - The total amount raised from Hong Kong IPOs exceeded 230 billion HKD as of November, more than doubling year-on-year, with new consumption, technology, and pharmaceuticals being the main sectors for listings [2] Group 2 - The conference featured prominent speakers, including economists and analysts from Morgan Stanley, DBS Bank, and Industrial Securities, who discussed liquidity trends and valuation opportunities in the Hong Kong stock market [4] - The awards ceremony recognized 231 companies and their management teams across 25 categories, highlighting excellence in governance, innovation, and market resilience [5][6] Group 3 - The award categories included "2025 Golden Hong Kong Stock Award," "Best Hong Kong Stock Connect Company," and "Most Valuable AI Company," among others, showcasing a diverse range of industries from traditional sectors to cutting-edge technologies [8][9][10][11] - The event emphasized the importance of corporate governance and innovation in achieving recognition and success in the capital market [6][35] Group 4 - Future events, including the "Zhitong Finance New Year Strategy Meeting" and the "Third China Overseas Fund Summit," are planned to continue fostering connections between industries and capital markets [35]

Market Overview - The Hong Kong stock market showed a slight upward trend, with the Hang Seng Index rising by 0.67% to close at 26,033.26 points, and the Hang Seng Tech Index increasing by 0.82% to 5,644.76 points [1] - Major technology stocks mostly rose, with Alibaba up 2.24%, Tencent up 1.31%, and JD Group up 0.52%. However, Xiaomi fell by 1.76% and Meituan dropped by 2.88% [1] - The metals sector saw significant gains, with China Nonferrous Mining rising over 13% [1] - Cryptocurrency-related stocks generally declined, with New Fire Technology Holdings down over 9% [1] Company News - Meituan reported Q3 revenue of 95.5 billion yuan, a year-on-year increase of 2%, but its core local business operating profit turned negative, resulting in a loss of 14.1 billion yuan [2] - China Gas reported revenue of 34.481 billion HKD and a profit of 1.334 billion HKD for the six months ending September 30, 2025 [3] - Yingtong Holdings reported a revenue of 1.028 billion RMB, a year-on-year decrease of 3.42%, but net profit increased by 15.4% to 133 million RMB [3] - Jihai Resources reported a revenue of 450 million RMB, a year-on-year increase of 23.41%, with a net profit of 88.127 million RMB, up 2.98% [3] - Yuhua Education reported annual revenue of 2.497 billion RMB, a year-on-year increase of 5.4%, and a net profit of 930 million RMB, up 133.2% [3] - Huitai Textile reported mid-term revenue of 2.524 billion HKD, a year-on-year decrease of 6.72%, and a net profit of 79.322 million HKD, down 25.77% [3] - Huaxin Handbag International reported revenue of 432 million HKD, a year-on-year increase of 22.55%, and a profit of 48.262 million HKD, up 78.88% [4] Institutional Insights - GF Securities noted that the foundation for a bull market in Hong Kong stocks remains intact, but the evolution may present a "volatile upward, gradually rising" characteristic rather than a rapid increase [12] - Dongwu Securities indicated that short-term risk factors in Hong Kong stocks are decreasing, but a catalyst is needed for confirmation of a rebound [12] - Everbright Securities suggested that compared to previous bull markets, there is still significant room for index growth, but the duration of the bull market may be more important than the magnitude of the increase [12] - CICC highlighted that dividends have become a preferred choice in the current market environment, with the banking sector rebounding nearly 10% since the end of September [13]